The stock of CURATIVE BIOSCIENCES INC (OTCMKTS:CBDX) registered a decrease of 20% in short interest. CBDX’s total short interest was 1,200 shares in November as published by FINRA. Its down 20% from 1,500 shares, reported previously. With 1,800 shares average volume, it will take short sellers 1 days to cover their CBDX’s short positions.
The stock decreased 16.98% or $0.04 during the last trading session, reaching $0.22. About 53,171 shares traded or 113.12% up from the average. Curative Biosciences, Inc. (OTCMKTS:CBDX) has 0.00% since November 14, 2017 and is . It has underperformed by 15.62% the S&P500.
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. The company has market cap of $6.95 million. It intends to manufacture and market natural health products and operate in the medical cannabis industry. It currently has negative earnings. The firm was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017.